Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

["... I am pleased that they have the skills"].

Nienaber A, Kämmer W, Noelle S, Rohde S, Schulz M.

Pflege Z. 2013 Mar;66(3):150-4. German. No abstract available.

PMID:
23513584
2.

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.

Kraus M, Rückrich T, Reich M, Gogel J, Beck A, Kammer W, Berkers CR, Burg D, Overkleeft H, Ovaa H, Driessen C.

Leukemia. 2007 Jan;21(1):84-92. Epub 2006 Oct 5.

PMID:
17024115
3.

Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

Balabanov S, Gontarewicz A, Ziegler P, Hartmann U, Kammer W, Copland M, Brassat U, Priemer M, Hauber I, Wilhelm T, Schwarz G, Kanz L, Bokemeyer C, Hauber J, Holyoake TL, Nordheim A, Brümmendorf TH.

Blood. 2007 Feb 15;109(4):1701-11. Epub 2006 Sep 28.

4.

Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.

Berg CP, Stein GM, Klein R, Pascu M, Berg T, Kammer W, Priemer M, Nordheim A, Schulze-Osthoff K, Gregor M, Wesselborg S, Berg PA.

Liver Int. 2006 Sep;26(7):846-55.

PMID:
16911468
5.

Comparative proteomic analysis of neoplastic and non-neoplastic germ cell tissue.

Zimmermann U, Junker H, Krämer F, Balabanov S, Kleist B, Kammer W, Nordheim A, Walther R.

Biol Chem. 2006 Apr;387(4):437-40.

PMID:
16606342
6.

ExbBD-dependent transport of maltodextrins through the novel MalA protein across the outer membrane of Caulobacter crescentus.

Neugebauer H, Herrmann C, Kammer W, Schwarz G, Nordheim A, Braun V.

J Bacteriol. 2005 Dec;187(24):8300-11.

7.

Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy.

Junker H, Späte K, Suofu Y, Walther R, Schwarz G, Kammer W, Nordheim A, Walker LC, Runge U, Kessler C, Popa-Wagner A.

Epilepsia. 2005 Mar;46(3):339-43.

8.

Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.

Lautwein A, Kraus M, Reich M, Burster T, Brandenburg J, Overkleeft HS, Schwarz G, Kammer W, Weber E, Kalbacher H, Nordheim A, Driessen C.

J Leukoc Biol. 2004 May;75(5):844-55. Epub 2004 Feb 13.

PMID:
14966190
9.

Improved sensitivity proteomics by postharvest alkylation and radioactive labelling of proteins.

Vuong GL, Weiss SM, Kammer W, Priemer M, Vingron M, Nordheim A, Cahill MA.

Electrophoresis. 2000 Jul;21(13):2594-605.

PMID:
10949135
10.

The two subunits of the interleukin-4 receptor mediate independent and distinct patterns of ligand endocytosis.

Friedrich K, Kammer W, Erhardt I, Brändlein S, Arnold S, Sebald W.

Eur J Biochem. 1999 Oct 1;265(1):457-65.

11.
12.

The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.

Lischke A, Moriggl R, Brändlein S, Berchtold S, Kammer W, Sebald W, Groner B, Liu X, Hennighausen L, Friedrich K.

J Biol Chem. 1998 Nov 20;273(47):31222-9.

13.

Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.

Moriggl R, Erhardt I, Kammer W, Berchtold S, Schnarr B, Lischke A, Groner B, Friedrich K.

Eur J Biochem. 1998 Jan 15;251(1-2):25-35.

14.

Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.

Haque SJ, Wu Q, Kammer W, Friedrich K, Smith JM, Kerr IM, Stark GR, Williams BR.

Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8563-8.

15.

Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.

Moriggl R, Berchtold S, Friedrich K, Standke GJ, Kammer W, Heim M, Wissler M, Stöcklin E, Gouilleux F, Groner B.

Mol Cell Biol. 1997 Jul;17(7):3663-78.

16.

Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling.

Kammer W, Lischke A, Moriggl R, Groner B, Ziemiecki A, Gurniak CB, Berg LJ, Friedrich K.

J Biol Chem. 1996 Sep 27;271(39):23634-7.

17.
18.
20.

[In-vitro antagonism of certain antibiotics in the agar diffusion test].

Kammer W, Neuhaus B.

Offentl Gesundheitswes. 1979 Feb;41(2):98-100. German. No abstract available.

PMID:
154635
21.

[In-vitro antagonism of Cefoxitin and Azlocilline in the agar diffusion test].

Kammer W, Neuhaus B.

Offentl Gesundheitswes. 1978 Sep;40(9):621. German. No abstract available.

PMID:
151835
22.

Fluid ingestion during distance running.

Costill DL, Kammer WF, Fisher A.

Arch Environ Health. 1970 Oct;21(4):520-5. No abstract available.

PMID:
5457228
23.

Skinfold estimates of body fat among marathon runners.

Costill DL, Bowers R, Kammer WF.

Med Sci Sports. 1970 Summer;2(2):93-5. No abstract available.

PMID:
5521081
24.

Fluid and electrolyte balance medical application.

KAMMER WF, NELSON HE, HUMMEL PR.

J Indiana State Med Assoc. 1952 May;45(5):405-8. No abstract available.

PMID:
14938602
25.

Treatment of postpneumonic thoracic empyema with sulfonamides; penicillin and repeated thoracenteses.

JOSEY AI, TRENIS JW, KAMMER WF.

Ann Intern Med. 1945 Nov;23:800-15. No abstract available.

PMID:
21003585

Supplemental Content

Loading ...
Support Center